{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:08:28Z","timestamp":1761764908642},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s11934-004-0064-0","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T07:43:43Z","timestamp":1181202223000},"page":"423-426","source":"Crossref","is-referenced-by-count":38,"title":["Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder"],"prefix":"10.1007","volume":"5","author":[{"given":"David R.","family":"Staskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Harnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"64_CR1","unstructured":"Ditropan XL product package insert. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc.; June 30, 2004."},{"key":"64_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","volume":"57","author":"PV Kerrebroeck","year":"2001","unstructured":"Kerrebroeck PV, Kreder K, Jonas U: Tolterodine once-daily: superior efficacy and tolerability in the treatment of overactive bladder. Urology 2001, 57:414\u2013421.","journal-title":"Urology"},{"key":"64_CR3","first-page":"600","volume":"23","author":"D Rudy","year":"2004","unstructured":"Rudy D, Kline K, Goldberg K: A multicenter, randomized, placebocontrolled trial of trospium chloride in overactive bladder patients [Abstract 144]. Neurourol Urodyn 2004, 23:600\u2013601. Reports on efficacy and safety findings of large, double-blind, placebo-controlled phase-3 study of trospium chloride in patients with overactive bladder.","journal-title":"Neurourol Urodyn"},{"key":"64_CR4","unstructured":"Date on file. Indevus Pharmaceuticals, Inc., Lexington, MA."},{"key":"64_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF00191165","volume":"47","author":"A Pietzko","year":"1994","unstructured":"Pietzko A, Dimpfel W, Schwantes U, et al.: Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol 1994, 47:337\u2013343.","journal-title":"Eur J Clin Pharmacol"},{"key":"64_CR6","first-page":"497","volume":"19","author":"W Dimpfel","year":"2000","unstructured":"Dimpfel W, Todorova A, Vonderheid B: Electrophysiological evaluation of potential adverse effects of tolterodine, oxybutynin, and trospium chloride on the central nervous system [Abstract]. Neurourol Urodyn 2000, 19:497\u2013498.","journal-title":"Neurourol Urodyn"},{"key":"64_CR7","first-page":"217","volume":"50","author":"KW Herberg","year":"1999","unstructured":"Herberg KW: General and traffic safety and the effects of incontinence medication: new studies on the safety potential of urological anticholinergics. Die Medizinishce Welt 1999, 50:217\u2013222.","journal-title":"Die Medizinishce Welt"},{"key":"64_CR8","first-page":"461","volume":"43","author":"HP Breuel","year":"1993","unstructured":"Breuel HP, Murtz G, Bondy S, et al.: Safety and tolerance of trospium chloride in the high dose range. Arzneimittelforschung 1993, 43:461\u2013464.","journal-title":"Arzneimittelforschung"},{"key":"64_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1469-8986.1973.tb00801.x","volume":"10","author":"E Hoddes","year":"1973","unstructured":"Hoddes E, Zarcone V, Smythe H, et al.: Quantification of sleepiness: a new approach. Psychophysiology 1973, 10:431\u2013436. Provides summary of the validation of the Stanford Sleepiness Scale.","journal-title":"Psychophysiology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-004-0064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-004-0064-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-004-0064-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-004-0064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T12:23:06Z","timestamp":1652617386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-004-0064-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["64"],"URL":"https:\/\/doi.org\/10.1007\/s11934-004-0064-0","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}